Menu
Back to Journals » Drug Design, Development and Therapy » Volume 15
Original Research
No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,543 | Dovepress* | 4,074+ | 548 | 4,622 | |
| PubMed Central* | 469 | 149 | 618 | ||
| Totals | 4,543 | 697 | 5,240 | ||
| *Since 28 April 2021 | |||||
View citations on PubMed Central and Google Scholar